ADVENZYMES \u2014 Recent Activity

How The Narrative On Advanced Enzyme Technologies (NSEI:ADVENZYMES) Is Shifting Around The ₹370 Fair Value

The fair value estimate for Advanced Enzyme Technologies is held at ₹370.0, so the latest model update does not shift the headline price target. Bullish and bearish analysts are reading this steady figure differently, with some seeing it as confirmation of a stable valuation anchor and others viewing it as a cap on near term upside. As you read on, you will see how to interpret these signals and track how the story changes with future updates. Analyst Price Targets don't always capture the...

Click to open →

How The Advanced Enzyme Technologies (NSEI:ADVENZYMES) Story Is Shifting With An Unchanged ₹370 Valuation

The fair value estimate for Advanced Enzyme Technologies stays at ₹370.0, with analysts deciding not to shift the price target despite refreshed model inputs. Supportive voices see this as confirmation that the existing valuation still fits the updated assumptions, while cautious analysts highlight that an unchanged target may point to limited room for re rating based only on the latest tweaks. As you read on, you will see how these differing views shape the evolving narrative around the...

Click to open →

How The Advanced Enzyme Technologies (NSEI:ADVENZYMES) Narrative Is Shifting Around A ₹370 Valuation

The fair value estimate for Advanced Enzyme Technologies has been kept steady at ₹370.0 per share, with no change in the headline price target despite refreshed model inputs. Bullish and bearish analysts are reading that unchanged ₹370.0 figure very differently, tying it to views on free cash flow trends, portfolio clean up and how much weight to put on future assumptions. As you read on, you will see how this updated narrative is evolving and what it could mean for how you track the stock...

Click to open →

Advanced Enzyme Technologies Ltd (BOM:540025) Q3 2026 Earnings Call Highlights: Resilient ...

Despite global disruptions, Advanced Enzyme Technologies Ltd (BOM:540025) reports strong year-to-date performance, with notable growth in animal healthcare and bioprocessing segments.

Click to open →

Advanced Enzyme Technologies Ltd (BOM:540025) Q2 2026 Earnings Call Highlights: Strong ...

Advanced Enzyme Technologies Ltd (BOM:540025) reports robust revenue and profit growth for Q2 FY26, despite facing tariff-related hurdles in the US market.

Click to open →